Troponin i alterations detected by multiple-reaction monitoring: How might this impact the study of heart failure?

Expert Review of Proteomics

Volumn 10, Issue 1, 2013, Pages 5-8

  Kirk, Jonathan A ^a   Zhang, Pingbo ^a   Murphy, Anne M ^a   Van Eyk, Jennifer E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cardiac troponin I; constrained multiple reaction monitoring; heart failure; mass spectrometry; phosphorylation

Indexed keywords

BIOLOGICAL MARKER; TROPONIN I;

ENZYME LINKED IMMUNOSORBENT ASSAY; HEART FAILURE; HUMAN; MASS SPECTROMETRY; MONITORING; MORBIDITY; MULTIPLE REACTION MONITORING; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REVIEW;

BIOLOGICAL MARKERS; HEART FAILURE; HUMANS; MASS SPECTROMETRY; PHOSPHORYLATION; TROPONIN I;

EID: 84874057938     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/epr.12.77     Document Type: Review

References (20)

1. Zhang P, Kirk JA, Ji W et al. Multiple reaction monitoring to identify site-specific troponin I phosphorylated residues in the failing human heart. Circulation 126(15), 1828-1837 (2012).
2. Roger VL, Go AS, Lloyd-Jones DM et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2012 update: A report from the American Heart Association. Circulation 125(1), e2-e220 (2012).
3. Stull JT, Brostrom CO, Krebs EG. Phosphorylation of the inhibitor component of troponin by phosphorylase kinase. J. Biol. Chem. 247(16), 5272-5274 (1972).
4. Solaro RJ, Moir AJ, Perry SV. Phosphorylation of troponin I and the inotropic effect of adrenaline in the perfused rabbit heart. Nature 262(5569), 615-617 (1976).
5. Moir AJ, Perry SV. The sites of phosphorylation of rabbit cardiac troponin I by adenosine 3́:5́-cyclic monophosphatedependent protein kinase. Effect of interaction with troponin C. Biochem. J. 167(2), 333-343 (1977).
6. Kooij V, Saes M, Jaquet K et al. Effect of troponin I Ser23/24 phosphorylation on Ca2+-sensitivity in human myocardium depends on the phosphorylation background. J. Mol. Cell. Cardiol. 48(5), 954-963 (2010).
7. Varian KD, Biesiadecki BJ, Ziolo MT, Davis JP, Janssen PM. Staurosporine inhibits frequency-dependent myofilament desensitization in intact rabbit cardiac trabeculae. Biochem. Res. Int. 2012, 290971 (2012).
8. Charo DN, Ho M, Fajardo G et al. Endogenous regulation of cardiovascular function by apelin-APJ. Am. J. Physiol. Heart Circ. Physiol. 297(5), H1904-H1913 (2009).
9. Kirk JA, MacGowan GA, Evans C et al. Left ventricular and myocardial function in mice expressing constitutively pseudophosphorylated cardiac troponin I. Circ. Res. 105(12), 1232-1239 (2009).
10. Zabrouskov V, Ge Y, Schwartz J, Walker JW. Unraveling molecular complexity of phosphorylated human cardiac troponin I by top down electron capture dissociation/ electron transfer dissociation mass spectrometry. Mol. Cell Proteomics 7(10), 1838-1849 (2008).
11. Sakthivel S, Finley NL, Rosevear PR et al. In vivo and in vitro analysis of cardiac troponin I phosphorylation. J. Biol. Chem. 280(1), 703-714 (2005).
12. Arteaga GM, Warren CM, Milutinovic S, Martin AF, Solaro RJ. Specific enhancement of sarcomeric response to Ca2+ protects murine myocardium against ischemiareperfusion dysfunction. Am. J. Physiol. Heart Circ. Physiol. 289(5), H2183-H2192 (2005).
13. Wolska BM, Arteaga GM, Peña JR et al. Expression of slow skeletal troponin I in hearts of phospholamban knockout mice alters the relaxant effect of beta-adrenergic stimulation. Circ. Res. 90(8), 882-888 (2002).
14. Noland TA, Raynor RL, Kuo JF. Identification of sites phosphorylated in bovine cardiac troponin-I and troponin-T by protein kinase-C and comparative substrate activity of synthetic peptides containing the phosphorylation sites. J. Biol. Chem. 264(34), 20778-20785 (1989).
15. Wang H, Grant JE, Doede CM, Sadayappan S, Robbins J, Walker JW. PKC-betaII sensitizes cardiac myofilaments to Ca2+ by phosphorylating troponin I on threonine-144. J. Mol. Cell. Cardiol. 41(5), 823-833 (2006).
16. Buscemi N, Foster DB, Neverova I, Van Eyk JE. p21-activated kinase increases the calcium sensitivity of rat tritonskinned cardiac muscle fiber bundles via a mechanism potentially involving novel phosphorylation of troponin I. Circ. Res. 91(6), 509-516 (2002).
17. Oliveira SM, Zhang YH, Solis RS et al. AMP-activated protein kinase phosphorylates cardiac troponin I and alters contractility of murine ventricular myocytes. Circ. Res. 110(9), 1192-1201 (2012).
18. Sheehan KA, Ke Y, Wolska BM, Solaro RJ. Expression of active p21-activated kinase-1 induces Ca2+ flux modification with altered regulatory protein phosphorylation in cardiac myocytes. Am. J. Physiol., Cell Physiol. 296(1), C47-C58 (2009).
19. Januzzi JL Jr, Filippatos G, Nieminen M, Gheorghiade M. Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section. Eur. Heart J. 33(18), 2265-2271 (2012).
20. Mcdonough LR, Van Eyk JE. Prepare to meet your markers: making the most out of troponin I degradation. American Heart Association Monograph on Cardiac Biomarkers. Adams III J, Apple FS, Jaffe AS, Wu AHB (Eds). Furtura Press, NY, USA, 13-22 (2001).